Stocks · Coverage Archive

$REPL

14.77 ▲ 5.12%

Every Regards of Wallstreet article on $REPL, newest first — 1 story and counting.

Followed tickers pin their next report date and latest coverage to the homepage and the earnings calendar.

  1. 2026-07-31 · 7 min read

    Why Is Replimune (REPL) Stock Up 127%? An FDA Panel Backed RP1 After Two Rejections, and the Decision Lands This Weekend

    Replimune surged 127% after an FDA panel voted 10-3 that RP1 works in advanced melanoma, six days after the stock crashed 32%. The PDUFA date is August 2. Why this is not over.

New to options? See our plain-English strategy playbook →

The Week-Ahead Brief

Don’t miss next week’s setups. Get the Saturday brief.

Latest issue, Aug 17“The consumer cracked on Friday. Six retailers answer for it this week.”

Every Saturday: next week’s earnings dates, Fed days and the trades worth watching, from the same desk that writes the week-ahead hub. Free, built for retail investors.

Subscribing means we email you the newsletter and nothing else. No spam, no sharing your address, unsubscribe in one click. See the privacy policy.